Otolaryngology Doctors in Houma, LA Accepting Medicare

3 Otolaryngology doctors found. Showing 1 - 3

Dr. Matthew Beyer, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 505 Dunn Street, Houma, LA 70360 Phone: 985-872-0423    Fax: 985-872-6600

Dr. Chad Michael Simon, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 505 Dunn St, Houma, LA 70360 Phone: 985-872-0423

Dr. David Lee Hagen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 505 Dunn Street, Houma, LA 70360 Phone: 985-872-0423    Fax: 985-872-6600

News Archive

Project A.L.S. and Robert Packard Center for ALS Research partner in $15M research initiative

Project A.L.S. (New York, NY) and the Robert Packard Center for ALS Research at Johns Hopkins University (Baltimore, MD) announced that they will partner on P2 ALS, a $15 million initiative designed to advance ALS (Lou Gehrig's disease) research exponentially over the next three years.

Study links dietary fat content with excess of abdominal fat in adolescents, irrespective of physical exercise

The prevalence of excess weight and obesity among adolescents and, as a result, the concomitant problems, has increased considerably in recent years. A study by the UPV/EHU has confirmed that, irrespective of the total calories consumed and the physical activity done, an excessive proportion of fat in the diet leads to a greater accumulation of fat in the abdomen.

About 26% of U.S. girls, women ages 14 to 59 have HPV

Of U.S. women and girls ages 14 to 59, about 24.9 million women, or 26.8%, have the human papillomavirus, and about 2% of women and girls in the age group have HPV strains 16 or 18, which together cause about 70% of cervical cancer cases, according to a study published in the Feb. 28 issue of the Journal of the American Medical Association, the Wall Street Journal reports.

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

Study provides direct evidence for persistent activity in medial entorhinal cortex layer neurons

UCLA researchers have for the first time measured the activity of a brain region known to be involved in learning, memory and Alzheimer's disease during sleep. They discovered that this part of the brain behaves as if it's remembering something, even under anesthesia, a finding that counters conventional theories about memory consolidation during sleep.

Read more Medical News

› Verified 6 days ago